VNTR of the ATXN2 gene as a biomarker of thrombophlebitis in patients with type 2 diabetes and COVID-19

Claudia B. Montano-Montejano; Diana Garcia-Cruz; Jose Dominguez-Rodas; Alejandro Dominguez-Cabrera; Eric Ruiz-Balderas; Sabina Lopez-Toledo; Sergio A. Ramirez-Garcia

ArticleOPEN ACCESS

VNTR of the ATXN2 gene as a biomarker of thrombophlebitis in patients with type 2 diabetes and COVID-19

Montano-Montejano C
Garcia-Cruz D
Dominguez-Rodas J
et al.

Cirugia y Cirujanos (English Edition)

DOI: 10.24875/CIRU.21000595

0Citations

3Readers

Get full text

Cite

CITATION STYLE

APA

Montano-Montejano, C. B., Garcia-Cruz, D., Dominguez-Rodas, J., Dominguez-Cabrera, A., Ruiz-Balderas, E., Lopez-Toledo, S., & Ramirez-Garcia, S. A. (2022, May 1). VNTR of the ATXN2 gene as a biomarker of thrombophlebitis in patients with type 2 diabetes and COVID-19. Cirugia y Cirujanos (English Edition). Permanyer Publications. https://doi.org/10.24875/CIRU.21000595

VNTR of the ATXN2 gene as a biomarker of thrombophlebitis in patients with type 2 diabetes and COVID-19

Cite

Register to see more suggestions